Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord - PubMed (original) (raw)
Comparative Study
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord
Karim Fouad et al. J Neurosci. 2005.
Abstract
Numerous obstacles to successful regeneration of injured axons in the adult mammalian spinal cord exist. Consequently, a treatment strategy inducing axonal regeneration and significant functional recovery after spinal cord injury has to overcome these obstacles. The current study attempted to address multiple impediments to regeneration by using a combinatory strategy after complete spinal cord transection in adult rats: (1) to reduce inhibitory cues in the glial scar (chondroitinase ABC), (2) to provide a growth-supportive substrate for axonal regeneration [Schwann cells (SCs)], and (3) to enable regenerated axons to exit the bridge to re-enter the spinal cord (olfactory ensheathing glia). The combination of SC bridge, olfactory ensheathing glia, and chondroitinase ABC provided significant benefit compared with grafts only or the untreated group. Significant improvements were observed in the Basso, Beattie, and Bresnahan score and in forelimb/hindlimb coupling. This recovery was accompanied by increased numbers of both myelinated axons in the SC bridge and serotonergic fibers that grew through the bridge and into the caudal spinal cord. Although prominent descending tracts such as the corticospinal and reticulospinal tracts did not successfully regenerate through the bridge, it appeared that other populations of regenerated fibers were the driving force for the observed recovery; there was a significant correlation between numbers of myelinated fibers in the bridge and improved coupling of forelimb and hindlimb as well as open-field locomotion. Our study tests how proven experimental treatments interact in a well-established animal model, thus providing needed direction for the development of future combinatory treatment regimens.
Figures
Figure 1.
Experimental design for the cell grafting and cABC treatment after the removal of the thoracic 8 segment of the spinal cord.
Figure 2.
Effectiveness of cABC application as demonstrated by the use of antibodies against either intact (1D1, CS-56) or digested (2B6) chondroitin sulfate. *p < 0.05.
Figure 3.
Comparison of the open-field locomotion scores between the different treatment groups quantified with the BBB score (A) and by using the percentage of successful forelimb/hindlimb coupling (B). C, The time course of recovery shows treatment-induced benefits start to become apparent at 8 weeks after surgery. The dots represent the scores of single animals. *p < 0.05, **p < 0.01.
Figure 4.
Video sequence from a rat treated with OEG and Schwann cell grafts as well as with cABC. Note the range of leg motion as well as the alternation between the forelimb and hindlimb movements. The panels are organized in rows from left to right.
Figure 5.
Sensory testing using von Frey hairs at the base of the tail shows increased responsiveness in all of the treated groups. *p < 0.05.
Figure 6.
A, 5-HT-positive fibers were found to grow into the caudal spinal cord. The quantification of these fibers in the caudal spinal cord is illustrated in B. As documented in C, there was no correlation between individual functional recovery and the number of 5-HT-positive fibers in the caudal spinal cord. *p < 0.05.
Figure 7.
Significantly greater numbers of peripheral-myelinated axons (arrow) are present within the Schwann cell bridge after digestion of CSPGs with chondroitinase ABC. Animals with grafts only (A) and animals with grafts and cABC (B) are shown. Scale bar, 150 μm.
Figure 8.
Counts of myelinated axons in the middle of the bridge showed a significant (p < 0.01) increase (A) in the group with grafts and cABC. B, The number of blood vessels in the bridge was not different between the groups. C, There was a significant correlation (_r_2 = 0.63) between individual functional recovery and the number of myelinated axons.
Similar articles
- Neuronal populations capable of regeneration following a combined treatment in rats with spinal cord transection.
Vavrek R, Pearse DD, Fouad K. Vavrek R, et al. J Neurotrauma. 2007 Oct;24(10):1667-73. doi: 10.1089/neu.2007.0290. J Neurotrauma. 2007. PMID: 17970629 - Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury.
Kanno H, Pressman Y, Moody A, Berg R, Muir EM, Rogers JH, Ozawa H, Itoi E, Pearse DD, Bunge MB. Kanno H, et al. J Neurosci. 2014 Jan 29;34(5):1838-55. doi: 10.1523/JNEUROSCI.2661-13.2014. J Neurosci. 2014. PMID: 24478364 Free PMC article. - Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants.
Ramón-Cueto A, Plant GW, Avila J, Bunge MB. Ramón-Cueto A, et al. J Neurosci. 1998 May 15;18(10):3803-15. doi: 10.1523/JNEUROSCI.18-10-03803.1998. J Neurosci. 1998. PMID: 9570810 Free PMC article. - Novel combination strategies to repair the injured mammalian spinal cord.
Bunge MB. Bunge MB. J Spinal Cord Med. 2008;31(3):262-9. doi: 10.1080/10790268.2008.11760720. J Spinal Cord Med. 2008. PMID: 18795474 Free PMC article. Review. - Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury.
Bregman BS, Coumans JV, Dai HN, Kuhn PL, Lynskey J, McAtee M, Sandhu F. Bregman BS, et al. Prog Brain Res. 2002;137:257-73. doi: 10.1016/s0079-6123(02)37020-1. Prog Brain Res. 2002. PMID: 12440372 Review.
Cited by
- Neuroregeneration Improved by Sodium-D,L-Beta-Hydroxybutyrate in Primary Neuronal Cultures.
Ari C, D'Agostino DP, Cha BJ. Ari C, et al. Pharmaceuticals (Basel). 2024 Aug 31;17(9):1160. doi: 10.3390/ph17091160. Pharmaceuticals (Basel). 2024. PMID: 39338322 Free PMC article. - Treatment of spinal cord injury with biomaterials and stem cell therapy in non-human primates and humans.
Olaya AMS, Almeida FM, Martinez AMB, Marques SA. Olaya AMS, et al. Neural Regen Res. 2025 Feb 1;20(2):343-353. doi: 10.4103/NRR.NRR-D-23-01752. Epub 2024 May 24. Neural Regen Res. 2025. PMID: 38819038 Free PMC article. - Brain Plasticity in Patients with Spinal Cord Injuries: A Systematic Review.
Calderone A, Cardile D, De Luca R, Quartarone A, Corallo F, Calabrò RS. Calderone A, et al. Int J Mol Sci. 2024 Feb 13;25(4):2224. doi: 10.3390/ijms25042224. Int J Mol Sci. 2024. PMID: 38396902 Free PMC article. Review. - Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury.
Yang Y, Ma B, Chen J, Liu D, Ma J, Li B, Hao J, Zhou X. Yang Y, et al. Clin Epigenetics. 2024 Feb 21;16(1):30. doi: 10.1186/s13148-024-01639-5. Clin Epigenetics. 2024. PMID: 38383473 Free PMC article. Review. - Spinal cord injury: molecular mechanisms and therapeutic interventions.
Hu X, Xu W, Ren Y, Wang Z, He X, Huang R, Ma B, Zhao J, Zhu R, Cheng L. Hu X, et al. Signal Transduct Target Ther. 2023 Jun 26;8(1):245. doi: 10.1038/s41392-023-01477-6. Signal Transduct Target Ther. 2023. PMID: 37357239 Free PMC article. Review.
References
- Aebischer P, Guenard V, Winn SR, Valentini RF, Galletti PM (1988) Blindended semipermeable guidance channels support peripheral nerve regeneration in the absence of a distal nerve stump. Brain Res 454: 179-187. - PubMed
- Antri M, Orsal D, Barthe JY (2002) Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist. Eur J Neurosci 16: 467-476. - PubMed
- Bamber NI, Li H, Lu X, Oudega M, Aebischer P, Xu XM (2001) Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur J Neurosci 13: 257-268. - PubMed
- Bareyre FM, Kerschensteiner M, Raineteau O, Mettenleiter TC, Weinmann O, Schwab ME (2004) The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 7: 269-277. - PubMed
- Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12: 1-21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous